Intermediatebiotechnology
Cloning: Dolly the Sheep
Overview
Dolly (1996, Roslin Institute) was the first mammal cloned from an adult somatic cell: a mammary cell nucleus transferred into an enucleated egg, fused, and implanted. She proved differentiated nuclei retain full genetic potential (reprogramming), overturning dogma. Cloning remains inefficient (1-5% live births) with epigenetic abnormalities; therapeutic cloning (SCNT for patient stem cells) is distinct from reproductive cloning.
Learning objectives
- Describe somatic cell nuclear transfer
- Explain what Dolly proved about differentiation
- Discuss cloning efficiency and abnormalities
- Distinguish reproductive vs therapeutic cloning
How Dolly was made
Take an udder cell from a Finn Dorset ewe; starve it into G0; transfer its nucleus into an enucleated Scottish Blackface egg; fuse with electric pulse; culture to blastocyst; implant into a surrogate. Dolly: genetically Finn Dorset, born July 5, 1996, announced 1997. 277 attempts, one lamb.
SCNT's inefficiency was part of the announcement: cloning barely worked, even in expert hands.
What it proved
An adult differentiated nucleus, reprogrammed by egg cytoplasm, can direct full development: differentiation does not irreversibly alter DNA (except immune rearrangements). Gurdon's frog nuclear transfers (1960s) hinted it; Dolly proved it in mammals. Nobel 2012 (Gurdon/Yamanaka) honored reprogramming.
Dolly showed cell identity is written in chromatin marks the egg can erase.
Problems: telomeres and imprinting
Clones show shortened telomeres (Dolly's were shorter, though she lived 6.5 years), large-offspring syndrome, placental defects, and imprinting errors: the egg imperfectly resets somatic epigenetic marks. Efficiency remains ~1-5% across species; primates resisted until 2018 (macaques Zhong Zhong/Hua Hua).
Most SCNT embryos fail because epigenetic resetting is hit-or-miss.
Therapeutic vs reproductive cloning
Reproductive: clone to birth (banned/condemned for humans worldwide). Therapeutic: SCNT blastocyst -> patient-matched embryonic stem cells for research/therapy, never implanted. iPSCs (Yamanaka factors) now offer reprogramming without eggs or embryos, largely superseding therapeutic cloning.
Yamanaka's four factors reprogram without eggs: Dolly's conceptual heir, ethically cleaner.
Key points
- SCNT: somatic nucleus into enucleated egg -> clone
- Dolly proved adult nuclei retain totipotency after reprogramming
- Efficiency 1-5%; epigenetic errors cause abnormalities
- Reproductive cloning condemned; therapeutic cloning largely replaced by iPSCs
Common misconceptions
✓ Truth: She matched the nucleus donor (Finn Dorset), not the surrogate or egg donor (mitochondria excepted).
✓ Truth: Dolly aged mostly normally (arthritis, lung disease at 6.5); telomere-shortening fears were partly overstated.
Practice questions
Q1. Dolly was created by
- Embryo splitting
- Somatic cell nuclear transfer
- CRISPR
- Selective breeding
Adult mammary nucleus into an enucleated egg.
Q2. Dolly's significance was proving
- Cloning is efficient
- Differentiated adult nuclei can be reprogrammed to totipotency
- Sheep are smart
- Telomeres don't matter
Differentiation is epigenetic and reversible by egg cytoplasm.
Q3. Therapeutic cloning aims to produce
- Babies
- Patient-matched stem cells without implantation
- Livestock
- Organs for sale
SCNT blastocysts as a stem-cell source, never implanted.
Click a question to reveal the answer and explanation.
Frequently asked questions
Why starve the donor cell into G0?
Cell-cycle synchrony with the egg improves reprogramming: quiescent chromatin resets more readily.
What are iPSCs?
Induced pluripotent stem cells: adult cells reprogrammed by Oct4/Sox2/Klf4/c-Myc, embryo-free pluripotency.
Is human reproductive cloning possible?
Primate SCNT succeeded in 2018; human attempts are universally condemned and legally banned in most nations.